These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 9696456
1. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Eckhardt K, Li S, Ammon S, Schänzle G, Mikus G, Eichelbaum M. Pain; 1998 May; 76(1-2):27-33. PubMed ID: 9696456 [Abstract] [Full Text] [Related]
2. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Poulsen L, Brøsen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH. Eur J Clin Pharmacol; 1996 May; 51(3-4):289-95. PubMed ID: 9010701 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lötsch J, Roots I, Brockmöller J. Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548 [Abstract] [Full Text] [Related]
4. The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status. Fliegert F, Kurth B, Göhler K. Eur J Clin Pharmacol; 2005 Jun; 61(4):257-66. PubMed ID: 15906019 [Abstract] [Full Text] [Related]
5. Pharmacogenetic determination of the effects of codeine and prediction of drug interactions. Caraco Y, Sheller J, Wood AJ. J Pharmacol Exp Ther; 1996 Sep; 278(3):1165-74. PubMed ID: 8819499 [Abstract] [Full Text] [Related]
6. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. VanderVaart S, Berger H, Sistonen J, Madadi P, Matok I, Gijsen VM, de Wildt SN, Taddio A, Ross CJ, Carleton BC, Hayden MR, Koren G. Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374 [Abstract] [Full Text] [Related]
7. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics. Zahari Z, Ismail R. Drug Metab Pharmacokinet; 2014 Aug; 29(1):29-43. PubMed ID: 23759977 [Abstract] [Full Text] [Related]
8. Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake. Sindrup SH, Hofmann U, Asmussen J, Mikus G, Brøsen K, Nielsen F, Ingwersen SH, Broen Christensen C. Eur J Clin Pharmacol; 1996 Aug; 49(6):503-9. PubMed ID: 8706777 [Abstract] [Full Text] [Related]
9. The role of active metabolites in dihydrocodeine effects. Schmidt H, Vormfelde SV, Walchner-Bonjean M, Klinder K, Freudenthaler S, Gleiter CH, Gundert-Remy U, Skopp G, Aderjan R, Fuhr U. Int J Clin Pharmacol Ther; 2003 Mar; 41(3):95-106. PubMed ID: 12665158 [Abstract] [Full Text] [Related]
10. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G. Anesth Analg; 2000 Jul; 91(1):185-91. PubMed ID: 10866910 [Abstract] [Full Text] [Related]
11. The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects. Wu X, Yuan L, Zuo J, Lv J, Guo T. Eur J Clin Pharmacol; 2014 Jan; 70(1):57-63. PubMed ID: 24077935 [Abstract] [Full Text] [Related]
12. Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype. Mikus G, Trausch B, Rodewald C, Hofmann U, Richter K, Gramatté T, Eichelbaum M. Clin Pharmacol Ther; 1997 Apr; 61(4):459-66. PubMed ID: 9129563 [Abstract] [Full Text] [Related]
13. Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease. Molanaei H, Carrero JJ, Heimbürger O, Nordfors L, Lindholm B, Stenvinkel P, Odar-Cederlöf I, Bertilsson L. Eur J Clin Pharmacol; 2010 Mar; 66(3):269-73. PubMed ID: 19940985 [Abstract] [Full Text] [Related]
14. Codeine in post-operative pain. Study of the influence of sparteine phenotype and serum concentrations of morphine and morphine-6-glucuronide. Poulsen L, Riishede L, Brøsen K, Clemensen S, Sindrup SH. Eur J Clin Pharmacol; 1998 Aug; 54(6):451-4. PubMed ID: 9776433 [Abstract] [Full Text] [Related]
15. CYP2D6 ultrarapid metabolism and morphine/codeine ratios in blood: was it codeine or heroin? He YJ, Brockmöller J, Schmidt H, Roots I, Kirchheiner J. J Anal Toxicol; 2008 Mar; 32(2):178-82. PubMed ID: 18334103 [Abstract] [Full Text] [Related]
16. Impact of environmental and genetic factors on codeine analgesia. Desmeules J, Gascon MP, Dayer P, Magistris M. Eur J Clin Pharmacol; 1991 Mar; 41(1):23-6. PubMed ID: 1782973 [Abstract] [Full Text] [Related]
17. Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine Exposure. Badaoui S, Hopkins AM, Rodrigues AD, Miners JO, Sorich MJ, Rowland A. AAPS J; 2021 Jan 06; 23(1):15. PubMed ID: 33404848 [Abstract] [Full Text] [Related]
18. Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism. Mikus G, Bochner F, Eichelbaum M, Horak P, Somogyi AA, Spector S. J Pharmacol Exp Ther; 1994 Feb 06; 268(2):546-51. PubMed ID: 8113966 [Abstract] [Full Text] [Related]
19. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Zhou SF. Clin Pharmacokinet; 2009 Feb 06; 48(11):689-723. PubMed ID: 19817501 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype. García-Quetglas E, Azanza JR, Sádaba B, Muñoz MJ, Gil I, Campanero MA. Pharmacol Res; 2007 Feb 06; 55(2):122-30. PubMed ID: 17175164 [Abstract] [Full Text] [Related] Page: [Next] [New Search]